NLS
January 15, 2017
[aas_zone zone_id=”7909″]
Published: January 15, 2017
Top stories
Pharma Business – May 18, 2026
The company’s PPD Clinical Research Business is opening a new bioanalytical and biomarker laboratory within GoCo Health Innovation City.
Financing – May 18, 2026
The Series B funding will be used to power the company’s AI drug design engine, scale its business globally and progress its drug candidate pipeline.
It has been approved as the first and only aldosterone synthase inhibitor treatment for adults with hypertension.
Pharma article – May 18, 2026
The company is part of a new EU‑funded consortium developing an AI‑ and robotics‑driven manufacturing platform to secure access to critical medicines during shortages and supply chain disruptions.
Related posts
Advertising free banner - January 15, 2017
[aas_zone zone_id=”8010″]
[aas_zone zone_id=”7910″]
[aas_zone zone_id=”7913″]
[aas_zone zone_id=”7915″]
This site uses cookies
Read more about our privacy policy
The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.
The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.
The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.